US drug maker Moderna has announced the development of a single-dose vaccine candidate that is a combination of a Covid-19 booster as well as a seasonal flu jab.

"We believe our mRNA platform can solve the world's greatest health challenges, from diseases impacting millions to ultra-rare diseases impacting dozens, to medicines personalised down to the individual level," CEO Stephane Bancel said.